目的:观察苍附导痰汤对痰湿型多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者卵泡发育的影响,以期为痰湿型PCOS患者的治疗提供参考依据。方法:选择2021年1月至2021年12月收治的80例痰湿型PCOS患者为入选病例,随机分为对照组40例和试验组40例。试验组给予苍附导痰汤治疗6个月,对照组给予安慰剂,观察两组患者治疗前后痰湿证候积分、排卵率、脂肪因子(Apelin)和胰岛素抵抗指数(homeostasis model assessment-insulin resistance,HOMA-IR)水平,并分析Apelin和HOMA-IR相关性。结果:与对照组相比,试验组的平均年龄、不孕年限、体重指数等的差异无统计学意义(P＞0.05)。与治疗前相比,对照组治疗后痰湿证候积分、排卵率、Apelin、HOMA-IR水平的差异无统计学意义(P＞0.05);试验组治疗后痰湿证候积分降低(P＜0.05),排卵率升高(P＜0.05),Apelin、HOMA-IR水平均降低(P＜0.05)。Pearson相关性分析发现,治疗后Apelin水平与HOMA-IR水平之间呈正相关(P＜0.05)。结论:苍附导痰汤可有效改善痰湿型PCOS患者痰湿症状及胰岛素抵抗状况,降低血清Apelin水平,促进卵泡发育,提高排卵率。
Objective:To observe the effect of Cangfu Daotan decoction on follicular development in patients with phlegm-dampness type polycystic ovary syndrome (PCOS), hoping to provide reference for the treatment of PCOS patients with phlegm dampness. Methods: A total of 80 PCOS patients with phlegm dampness admitted in the Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine from January 2021 to December 2021 were selected and randomly divided into the control group (n=40) and the experimental group (n=40). The experimental group was treated with Cangfu Daotan decoction for 6 months, while the control group was given the placebo. The phlegm-dampness syndrome score, ovulation rate, adipose factor (Apelin), and insulin resistance index (HOMA-IR) of the two groups of patients were observed before and after treatment, and the correlation between Apelin and HOMA-IR was analyzed. Results: There was no statistically significant difference in the average age, infertility years, body mass index, etc. of the two groups (P＞0.05). No statistically significant difference in the score of phlegm-dampness syndrome, ovulation rate, Apelin, and HOMA-IR levels was found in the control group before and after treatment (P＞0.05). After treatment, the score of phlegm-dampness syndrome in the experimental group decreased (P＜0.05), the ovulation rate increased (P＜0.05), and the levels of Apelin and HOMA-IR decreased (P＜0.05). Pearson correlation analysis results showed a positive correlation (P＜0.05) between Apelin levels and HOMA-IR levels after treatment. Conclusion: Cangfu Daotan decocotion can effectively improve phlegm dampness symptoms and insulin resistance in patients with phlegm-dampness type PCOS, reduce serum Apelin levels, promote follicular development, and increase ovulation rate.
[1] 钱易, 马翔. 多囊卵巢综合征诊断标准解读[J]. 中国实用妇科与产科杂志, 2019, 35(3): 264-267.
[2] 张楚, 董浩旭, 宋玙璠, 等. 多囊卵巢综合征相关不孕症发病机制的研究进展[J]. 现代妇产科进展, 2020, 29(8): 629-631.
[3] 李逢春, 姚娟, 尹懿. 补肾化痰血方结合针灸对多囊卵巢综合征患者促排卵作用和性激素水平的影响[J]. 中外医学研究, 2021, 19(19): 117-119.
[4] 赖娟, 刘芳, 金鸥, 等. 苍柴调中汤辅助治疗对多囊卵巢综合征患者中医证候胰岛素抵抗及性激素水平的影响[J]. 中国妇幼保健, 2022, 37(16): 3017-3020.
[5] 谢蓬蓬, 曾蕾, 余璟玮, 等. 加减苍附导痰汤对多囊卵巢综合征脾虚痰湿证代谢和受孕情况的影响[J]. 中国实验方剂学杂志, 2021, 27(14): 87-92.
[6] 郑伊, 任青玲, 司雨, 等. 附子汤类方治疗痰湿型多囊卵巢综合征理论探析[J]. 环球中医药, 2022, 15(10): 1635-1638.
[7] 马玲. 苍附导痰汤调节痰湿型多囊卵巢综合征研究进展[J]. 中国民族民间医药, 2021, 30(4): 64-67.
[8] 兰丽琴, 毕小丽, 胡盛书, 等. 苍附导痰汤加减联合西医治疗对多囊卵巢综合征痰湿内阻型患者胰岛素抵抗指数, 内脂素水平的影响[J]. 河北中医, 2019, 41(3): 357-361.
[9] 张海燕. 从脂代谢角度探讨苍附导痰汤治疗痰湿型PCOS不孕症患者的作用机制[D]. 济南: 山东中医药大学, 2020.
[10] 郎爱娟. 苍附苁仙汤辅助治疗多囊卵巢综合征不孕症痰湿阻滞证42例临床观察[J]. 甘肃中医药大学学报, 2021, 38(3): 64-67.
[11] 连方, 崔文娜, 相姗. 苍附导痰汤对痰湿型PCOS卵巢颗粒细胞脂联素受体基因的表达及妊娠结局的影响[J]. 中华中医药杂志, 2020, 35(9): 4725-4728.
[12] 陈春悦, 王晨晔, 万凌屹, 等. 苍附导痰汤加减方对痰湿型多囊卵巢综合征患者性激素水平及排卵率的影响[J]. 中国优生与遗传杂志, 2019, 27(6): 761-762.
[13] 刘丽娜. 苍附导痰汤加减在多囊卵巢综合征患者治疗中的临床价值[J]. 现代医学与健康研究电子杂志, 2022, 6(11): 83-86.
[14] 张秋仔, 李宇青, 倪凯宾, 等. 苍附导痰汤联合来曲唑治疗肥胖型多囊卵巢综合征不孕的效果观察[J]. 中外医学研究, 2019, 17(33): 18-20.
[15] 范佳新, 凌娜. 加减苍附导痰汤治疗PCOS排卵障碍性不孕症临床观察[J]. 辽宁中医药大学学报, 2021, 23(3): 131-135.
[16] 杜静. Apelin在多囊卵巢综合征患者中表达及作用分子机制的研究[D]. 广州:南方医科大学, 2020.
[17] 蔡玉, 刁海丹. 血清TGF-β1、Apelin、CYP19A1水平与PCOS内分泌异常间的关系分析[J]. 生殖医学杂志, 2022, 31(4): 463-467.
[18] Yan JL, Wang AP, Cao JG, et al. Apelin/APJ system: an emerging therapeutic target for respiratory diseases[J]. Cell Mol Life Sci, 2020, 77(15): 2919-2930.
[19] 颜琪, 张慧霞, 张慧英. Apelin在多囊卵巢综合征中的研究进展[J]. 国际生殖健康/计划生育杂志, 2021, 40(1): 74-78.
